File

Peripheral vascular disease

ESC 2025 | SWEDEPAD 1 and 2: Paclitaxel-Coated Devices in Peripheral Artery Disease

In patients with peripheral artery disease, “improving” prognosis means relieving walking pain, increasing walking distance, preventing amputations,...

Dr. Juan Manuel Pérez - 3 September, 2025

Learn More

Acute coronary syndromes

ESC 2025 | OPTION-STEMI: Timing of Complete Revascularization During the Initial Hospitalization in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease

In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD), the optimal timing...

Dr. Juan Manuel Pérez - 3 September, 2025

Learn More

Coronary Disease

ESC 2025 | PULSE: Coronary CT Angiography vs Ischemia-Guided Follow-Up After Unprotected Left Main PCI

Courtesy of Dr. Juan Manuel Pérez. Unprotected left main (ULM) percutaneous coronary intervention (PCI) remains associated with a...

Dr. Juan Manuel Pérez - 3 September, 2025

Learn More

Pharmacology

Can Colchicine Reduce Post-TAVR Conduction Disturbances?

Courtesy of Dr. Juan Manuel Pérez. Partly caused by perioperative inflammation, conduction disturbances often follow TAVR. Colchicine, known...

Dr. Juan Manuel Pérez - 1 September, 2025

Learn More

Antithrombotic Anticoagulants

8 Questions About Left Atrial Appendage Closure: Contributions from the 2025 SCAI/HRS Review

Courtesy of Dr. Juan Manuel Pérez. Percutaneous left atrial appendage occlusion (LAAO) is an alternative to oral anticoagulation...

Dr. Juan Manuel Pérez - 28 August, 2025

Learn More

Left Atrial Apendix Closure

Clinical Impact of Peridevice Leak Following Left Atrial Appendage Closure

Left atrial appendage closure (LAAO) has consolidated as a valid strategy for thromboembolic event prevention in patients...

Dr. Omar Tupayachi - 26 August, 2025

Learn More

Peripheral vascular disease

Evolution of Renal Denervation at 24 Months

Arterial hypertension is a modifiable risk factor for cardiovascular events. In many cases, however, patients struggle to...

Dr. Carlos Fava - 26 August, 2025

Learn More

Chronic Coronary Syndromes

Pulsed-Field Ablation: Proximity to Coronary Vessels and the Unresolved Issue of Induced Vasospasm

Pulsed-field ablation (PFA) has emerged as a promising technique in the treatment of atrial fibrillation, thanks to...

Dr. Omar Tupayachi - 25 August, 2025

Learn More

ESC 2025 | SWEDEPAD 1 and 2: Paclitaxel-Coated Devices in Peripheral Artery Disease

ESC 2025 | OPTION-STEMI: Timing of Complete Revascularization During the Initial Hospitalization in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease

ESC 2025 | PULSE: Coronary CT Angiography vs Ischemia-Guided Follow-Up After Unprotected Left Main PCI

Can Colchicine Reduce Post-TAVR Conduction Disturbances?

8 Questions About Left Atrial Appendage Closure: Contributions from the 2025 SCAI/HRS Review

Clinical Impact of Peridevice Leak Following Left Atrial Appendage Closure

Evolution of Renal Denervation at 24 Months

Pulsed-Field Ablation: Proximity to Coronary Vessels and the Unresolved Issue of Induced Vasospasm

Last News

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Access